Roots Analysis Releases Market Insights Across Pharmaceutical and Technology Sectors

Roots Analysis, a market research firm, has released multiple key insights reports shedding light on significant trends and players across the pharmaceutical, life sciences, and medical device manufacturing sectors.

Reports published in June 2026 include in-depth analysis of small molecule drug conjugates (SMDCs) in oncology precision medicine and the heart failure drugs market. Another June release focuses on GLP-1 drugs, a transformative class for metabolic disorders, and on wearable injectors, which offer advanced drug delivery solutions.

In May 2026, Roots Analysis presented studies on the utilization of artificial intelligence (AI) in drug discovery, liquid biopsy diagnostics, and aseptic fill-finish manufacturing market trends. The reviews also cover contract manufacturing for medical devices and microbial fermentation CMO market trends.

April 2026 publications delve into antibody-drug conjugate (ADC) payload manufacturers, companies in the mRNA vaccine and therapeutics space, BCL-2 inhibitors for cancer treatment, adeno-associated viral (AAV) vectors for gene therapy manufacturing, and market trends in canine anti-aging. These releases offer expert analysis of rapidly evolving medical and technological domains.